Bannayan-Riley-Ruvalcaba syndrome: a cause of extreme macrocephaly and neurodevelopmental delay.
Affiliation
Department of Neurosciences, Our Lady's Children's Hospital, Crumlin, Dublin 12, , Ireland. nlynch@rcsi.ieIssue Date
2012-02-01T10:24:34ZMeSH
Autistic Disorder/etiology/geneticsChild
Child, Preschool
Craniofacial Abnormalities/etiology/genetics
DNA Mutational Analysis
Developmental Disabilities/etiology/genetics
Female
Genetic Predisposition to Disease
Genetic Testing
Hamartoma Syndrome, Multiple/complications/*diagnosis/genetics
Humans
Infant
Infant, Newborn
Lipoma/etiology/genetics
Male
Motor Skills Disorders/etiology/genetics
PTEN Phosphohydrolase/genetics
Retrospective Studies
Skin Diseases/etiology/genetics
Metadata
Show full item recordCitation
Arch Dis Child. 2009 Jul;94(7):553-4. Epub 2009 Mar 25.Journal
Archives of disease in childhoodDOI
10.1136/adc.2008.155663PubMed ID
19321504Abstract
BACKGROUND: Bannayan-Riley-Ruvalcaba syndrome (BRRS) is an autosomal dominant condition characterised by macrocephaly, developmental delay and subtle cutaneous features. BRRS results from mutations in the PTEN gene. In adults, PTEN mutations cause Cowden syndrome where, in addition to the macrocephaly, there is a higher risk of tumour development. Diagnosis of BRRS is often delayed as presentation can be variable, even within families. AIMS: To identify characteristics of this condition which might facilitate early diagnosis. Prompt diagnosis not only avoids unnecessary investigations in the child but potentially identifies heterozygote parents who are at risk of tumour development. METHODS AND RESULTS: Six children with a PTEN mutation were identified. All had extreme macrocephaly. Four parents and a male sibling were found to have a PTEN mutation on subsequent testing. Affected parents had extreme macrocephaly and a history of thyroid adenoma, or breast or skin lesions. All six children had presented to medical attention before the age of 2.5 years (3/6 were investigated as neonates), but the median age at diagnosis was 5 years. Four of the children had multiple investigations prior to identification of a PTEN mutation. CONCLUSION: BRRS should be considered in children with extreme macrocephaly as it is the most consistent clinical feature seen, particularly where there is a family history of macrocephaly.Language
engISSN
1468-2044 (Electronic)0003-9888 (Linking)
ae974a485f413a2113503eed53cd6c53
10.1136/adc.2008.155663
Scopus Count
Collections
Related articles
- Cutaneous lipoma in children: 5 cases with Bannayan-Riley-Ruvalcaba syndrome.
- Authors: Buisson P, Leclair MD, Jacquemont S, Podevin G, Camby C, David A, Heloury Y
- Issue date: 2006 Sep
- Bannayan-Riley-Ruvalcaba syndrome: further delineation of the phenotype and management of PTEN mutation-positive cases.
- Authors: Hendriks YM, Verhallen JT, van der Smagt JJ, Kant SG, Hilhorst Y, Hoefsloot L, Hansson KB, van der Straaten PJ, Boutkan H, Breuning MH, Vasen HF, Bröcker-Vriends AH
- Issue date: 2003
- Clinical presentation of PTEN mutations in childhood in the absence of family history of Cowden syndrome.
- Authors: Busa T, Milh M, Degardin N, Girard N, Sigaudy S, Longy M, Olshchwang S, Sobol H, Chabrol B, Philip N
- Issue date: 2015 Mar
- Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly.
- Authors: McBride KL, Varga EA, Pastore MT, Prior TW, Manickam K, Atkin JF, Herman GE
- Issue date: 2010 Jun
- Hemimegalencephaly with Bannayan-Riley-Ruvalcaba syndrome.
- Authors: Ghusayni R, Sachdev M, Gallentine W, Mikati MA, McDonald MT
- Issue date: 2018 Feb 1